Filing Details
- Accession Number:
- 0001209191-21-064540
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-15 17:59:52
- Reporting Period:
- 2021-11-15
- Accepted Time:
- 2021-11-15 17:59:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061027 | Viracta Therapeutics Inc. | VIRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1026765 | Ivor Royston | C/O Viracta Therapeutics, Inc. 2533 S Coast Hwy 101, Suite 210 Cardiff CA 92007 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-15 | 8,000 | $5.56 | 548,599 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,599 | Indirect | By spouse |
Billionaire Hedge Funds
